Skip to main content
. 2022 Aug 31;13:982346. doi: 10.3389/fimmu.2022.982346

Table 3.

Univariate Cox regression analysis for HBVr (N = 26).

HBVr (N = 2) No HBVr (N = 24) HR (95% CI) P-value
Female 0 (0) 7 (29.2) 0.016 (0.000-1451.874) 0.480
Age > 60 years 0 (0) 12 (50) 0.033 (0.000-62403.444) 0.644
Previous therapies≥4 2 (11.8) 15 (88.2) 0.849 (0.291-2.480) 0.765
Zanubrutinib 1 (50) 7 (29.2) 4.243 (0.231-78.065) 0.331
HBsAb-Positive 1 (50) 12 (50) 1.254 (0.077-20.400) 0.874
HBeAb-Positive 1 (50) 12 (50) 1 (0.063-15.988) 1

Comparisons in 26 patients with resolved HBV infection.

Data are presented as n (%) of patients.

HBVr, hepatitis B virus reactivation; HR, Hazard Ratio; CI, confidence interval; HbsAb, hepatitis B surface antibody; HbeAb, hepatitis B e antibody.